Atlas Trials

Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"

Clinical trial NCT04285983 · COMPLETED

Trial details

NCT number
NCT04285983
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Type 2 Diabetes Mellitus
Start date
2020-03-01
Primary completion
2023-01-31
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.